After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...

Dr. Reddy’s Laboratories (NYSE:RDY) is preparing to launch a generic version of semaglutide, the active ingredient in Novo ...

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the Stocks With Huge Catalysts on the Horizon. On July 9, Hims & Hers Health, ...

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to controversial practices around the sale of compounded drugs. These drugs are ...

Generic weight loss injection, 'Semaglutide,' hailed as affordable game-changer for patients The name-brand injection isn't covered by most insurances, costing patients around $1,500 out of pocket.

Teva Pharmaceuticals launched the first generic GLP-1 receptor agonist, liraglutide 1.8 mg, for patients aged 10 years or older with type 2 diabetes.“By launching an authorized generic for ...

Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk 's patent on its branded drugs Ozempic and Wegovy is set to expire in January. "Canada is a major ...